Anesthesic Techniques for Surgery of the Anterior Cruciate Ligament of the Knee in Ambulatory Surgery. Randomized Pilot Monocentric Trial
NCT ID: NCT02257164
Last Updated: 2015-07-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
48 participants
INTERVENTIONAL
2014-11-30
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In France, the surgery requires a duration of hospitalization from 2 to 4 days in the most cases. It is sometimes performed in ambulatory especially in the USA. But, at the home, pain requires powerful analgesics with their adverse events.
Today, no anesthesic technics for surgery of anterior cruciate ligament of the knee ensure in the same time optimal analgesia and optimal quadriceps locking. The main objective of the investigators study is to compare two analgesia techniques : femoral nerve block vs intra articular injection and obturator nerve block in surgery of the anterior cruciate ligament of the knee
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Adductor Canal Blockade in Anterior Cruciate Ligament Surgery
NCT02419261
Anterior Femoral and Adductor Canal Nerve Blocks in Peds Knees
NCT06590402
Adductor Canal Block Versus Femoral Nerve Block for Analgesia After Anterior Cruciate Ligament Reconstruction Arthroscopically
NCT02355093
Femoral Triangle + IPACK Blocks for ACL Reconstruction Analgesia
NCT05068063
Genicular Nerve Blocks for Anterior Cruciate Ligament Knee Surgery
NCT05720949
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
femoral nerve block
20 ml injection of 2 mg/ml ropivacaine in femoral nerve
Femoral nerve block
2 mg/ml
obturator nerve block and intraarticular injection
10 ml injection of 2 mg/ml ropivacaine in obturator nerve intraarticular injection : 10 ml of chlorhydrate ropivacaine (2 mg/ml) and 10ml of magnesium sulfate
obturator nerve block
intraarticular injection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Femoral nerve block
2 mg/ml
obturator nerve block
intraarticular injection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Major Patient
* indication of anterior cruciate ligament reconstruction
* informed consent for participation in the study
Exclusion Criteria
* Contraindication to peripheral nerve block
* Allergy to analgesic treatment
* Porphyria,
* Neurologic deficit
* Contraindication antiinflammatory drugs
* Simultaneous reconstruction of another ligament or complex gesture intended
* Patient treated with an anti-arrhythmic drug class III
* Patient with severe hepatic impairment
* Pregnant woman
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sylvie PASSOT, MD
Role: PRINCIPAL_INVESTIGATOR
CHU de Saint-Etienne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
PASSOT
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-002062-77
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
1408021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.